HOME >> BIOLOGY >> NEWS
Obscure Enzyme May Play Major Role In Heart Disease

NEW YORK, N.Y. and HAIFA, Israel, April 14, 1998 -- A little-known enzyme may play a significant role in preventing heart attack. A paper appearing April 15 in the prestigious Journal of Clinical Investigation, reports that paraoxonase, an enzyme present in the blood, prevents the oxidation of low-density lipoprotein or LDL, the "bad cholesterol" that is deposited in blood vessels and leads to coronary heart disease. The paper is by Professor Michael Aviram, a biochemist, head of the Lipid Research Laboratory, Faculty of Medicine at the Technion-Israel Institute of Technology and at Rambam Medical Center in Haifa, Israel.

"Paraoxonase is located in the blood on the HDL, the 'good' cholesterol, and it can break down oxidized LDL to non-harmful products," explains Aviram, adding that the discovery of this enzyme's activity opens a possible new route to prevention of heart diseases.

The real function of the enzyme has been something of a mystery since it was discovered more than 40 years ago. Its previously known function was to break down organophosphates, chemicals that are used as insecticides and poison gases. That activity was obviously not the complete story of paraoxonase, as humans do not normally contain these substances in their blood, Aviram realized.

Since the major focus of his past research has been the study of the mechanisms by which oxidized cholesterol and other oxidized lipids accumulate in arterial wall cells, leading to blockage of arteries and formation of atherosclerotic lesions, he decided to study the effect of the enzyme on oxidized lipids. Researchers had previously found a very strong inverse relationship between the activity of paraoxonase in the blood and the risk of heart disease. Lower activity is associated with higher risk. The present study helps us understand the mechanism behind that relationship.

In experiments with a
'"/>

Contact: Martha Molnar
martha@ats.org
(212) 307-2580
American Society for Technion - Israel Institute of Technology
15-Apr-1998


Page: 1 2 3

Related biology news :

1. Colorado State Scientists Tackle Genetic Makeup Of Obscure Bacteria
2. Enzyme maintaining chromosome ends is linked to bone cancer recurrence, decreased survival
3. Enzyme activation appears key in helping internal clock tell night from day
4. Enzyme fully degrades mad cow disease prion
5. Enzyme revealed that is key to funguss ability to breach immune system
6. Enzyme discovery sheds light on causes of rare disease, cancer
7. Enzyme could overcome industrial bleaching waste problems
8. Enzyme controls good cholesterol
9. Enzyme discovery to benefit homeland security, industry
10. Enzyme could aid cancer fight
11. Enzyme once thought harmful to Alzheimers patients now appears key to future treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Obscure Enzyme May Play Major Role Heart Disease

(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Global Wearable Technologies Market and Applications, Opportunities, ... and Forecast 2014-2020" report to their offering. ... devices that can be worn on the user,s ...
(Date:1/22/2015)... has launched its new NXG series of time clocks with ... higher standard for collecting attendance and labor data and complements ... touch screen interface and seamless connection to cloud-based iSolved, the ... for the small to mid-size employer. The G2 ...
(Date:12/22/2014)... 2014  NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... the growing mobile commerce market, announces it has retained famous ... the 2015 International CES debut of the Wocket™ biometric smart ... at the NXT-ID booth January 6th and 7 th , ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2Infinisource's NXG series sets new time clock standard 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
(Date:2/26/2015)... N.J. , Feb. 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... trade secrets lawsuit against Genewiz Inc. in excess of ... and utilized GenScript,s trade secrets, and that it improperly ... entered an order denying motions for judgment notwithstanding the ...
(Date:2/26/2015)... , Feb. 26, 2015   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... Ph.D., President and Chief Executive Officer of Regulus, will ... 35 th Annual Healthcare Conference on Wednesday, March ... being held at the Boston Marriott Copley Place.  ...
(Date:2/26/2015)... 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured ... against Genewiz Inc. in excess of $10 million. The ... trade secrets, and that it improperly hired one or ... order denying motions for judgment notwithstanding the verdict, a ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which takes ... Morial Convention Center in New Orleans, Louisiana, will ... 2015) displaying products and services used by the ... The Exposition will offer the latest innovations in ... chemistry; drug discovery; nanotechnology; life sciences to include ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Pittcon 2015 Announces Exposition Highlights 2
Cached News: